Literature DB >> 12022405

Rapidly growing members of the genus Mycobacterium affecting dogs and cats.

Spencer S Jang1, Dwight C Hirsh.   

Abstract

Rapidly growing members of the genus Mycobacterium were most often associated with chronic (2 to 72 months), nonhealing skin lesions of dogs and cats. Mycobacterium fortuitum (M. fortuitum) was the most commonly isolated mycobacterium obtained from these lesions, although M. chelonae-abscessus and M. flavescens were occasionally encountered. Isolates were tested in vitro to various antimicrobial agents and found to be susceptible to amikacin (100% of the isolates), cefoxitin (93.8%), ciprofloxacin (75%), clarithromycin (71.4%), doxycycline (28.6%), erythromycin (6.2%), gentamicin (68.8%), kanamycin (75%), minocycline (81.3%), streptomycin (14.3%), tobramycin (43.8%), trimethoprim/sulfonamides (57.1%), and vancomycin (15.4%).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12022405     DOI: 10.5326/0380217

Source DB:  PubMed          Journal:  J Am Anim Hosp Assoc        ISSN: 0587-2871            Impact factor:   1.023


  4 in total

1.  Mycobacterium porcinum causing panniculitis in the cat.

Authors:  Allison Cox; Tyler J Udenberg
Journal:  Can Vet J       Date:  2020-01       Impact factor: 1.008

2.  Mycobacterium avium: an Emerging Pathogen for Dog Breeds with Hereditary Immunodeficiencies.

Authors:  Giovanni Ghielmetti; Urs Giger
Journal:  Curr Clin Microbiol Rep       Date:  2020-08-18

Review 3.  Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients.

Authors:  Giulia Degiacomi; José Camilla Sammartino; Laurent Roberto Chiarelli; Olga Riabova; Vadim Makarov; Maria Rosalia Pasca
Journal:  Int J Mol Sci       Date:  2019-11-22       Impact factor: 5.923

4.  Feline mycobacterial disease in northern California: Epidemiology, clinical features, and antimicrobial susceptibility.

Authors:  Matthew J L Munro; Barbara A Byrne; Jane E Sykes
Journal:  J Vet Intern Med       Date:  2020-12-21       Impact factor: 3.175

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.